Literature DB >> 22170700

Elucidation of the structure-activity relationships of apelin: influence of unnatural amino acids on binding, signaling, and plasma stability.

Alexandre Murza1, Alexandre Parent, Elie Besserer-Offroy, Hugo Tremblay, Félix Karadereye, Nicolas Beaudet, Richard Leduc, Philippe Sarret, Éric Marsault.   

Abstract

Apelin is the endogenous ligand of the APJ receptor, a member of the G-protein-coupled receptor family. The apelin-APJ complex has been detected in many tissues and is emerging as a promising target for several pathophysiological conditions. There is currently little information on the structure-activity relationship (SAR) of the apelin hormone. In an effort to better delineate SAR, we synthesized analogues of apelin-13 modified at selected positions with unnatural amino acids, with a particular emphasis on the C-terminal portion. Analogues were then tested in binding and functional assays by evaluating Gi/o-mediated decreases in cAMP levels and by assessing β-arrestin2 recruitment to the APJ receptor. The plasma stability of new compounds was also assessed. Several analogues were found to possess increased binding and higher stability than the parent peptide.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170700     DOI: 10.1002/cmdc.201100492

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  21 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

Review 2.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

Review 3.  Regulation of the Apelinergic System and Its Potential in Cardiovascular Disease: Peptides and Small Molecules as Tools for Discovery.

Authors:  Sanju Narayanan; Danni L Harris; Rangan Maitra; Scott P Runyon
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

Review 4.  The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR.

Authors:  Nigel A Chapman; Denis J Dupré; Jan K Rainey
Journal:  Biochem Cell Biol       Date:  2014-08-20       Impact factor: 3.626

Review 5.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

6.  Apelin-36 Modulates Blood Glucose and Body Weight Independently of Canonical APJ Receptor Signaling.

Authors:  Hadas Galon-Tilleman; Hong Yang; Maria A Bednarek; Sandra M Spurlock; Kevin J Paavola; Brian Ko; Carmen To; Jian Luo; Hui Tian; Lutz Jermutus; Joseph Grimsby; Cristina M Rondinone; Anish Konkar; Daniel D Kaplan
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

7.  Directed Molecular Evolution of an Engineered Gammaretroviral Envelope Protein with Dual Receptor Use Shows Stable Maintenance of Both Receptor Specificities.

Authors:  Kristina Pagh Friis; Xavier Iturrioz; Jonas Thomsen; Rodrigo Alvear-Perez; Shervin Bahrami; Catherine Llorens-Cortes; Finn Skou Pedersen
Journal:  J Virol       Date:  2015-11-25       Impact factor: 5.103

8.  Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Authors:  Michel Demeule; Nicolas Beaudet; Anthony Régina; Élie Besserer-Offroy; Alexandre Murza; Pascal Tétreault; Karine Belleville; Christian Ché; Alain Larocque; Carine Thiot; Richard Béliveau; Jean-Michel Longpré; Éric Marsault; Richard Leduc; Jean E Lachowicz; Steven L Gonias; Jean-Paul Castaigne; Philippe Sarret
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

9.  Identification of potent pyrazole based APELIN receptor (APJ) agonists.

Authors:  Sanju Narayanan; Vineetha Vasukuttan; Sudarshan Rajagopal; Rangan Maitra; Scott P Runyon
Journal:  Bioorg Med Chem       Date:  2019-11-30       Impact factor: 3.641

Review 10.  International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand.

Authors:  Cai Read; Duuamene Nyimanu; Thomas L Williams; David J Huggins; Petra Sulentic; Robyn G C Macrae; Peiran Yang; Robert C Glen; Janet J Maguire; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.